Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

This cross-sectional study estimates the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA Netw Open
Main Authors: Haslam, Alyson, Gill, Jennifer, Prasad, Vinay
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Research Letter
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7063495/
https://ncbi.nlm.nih.gov/pubmed/32150268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.0423
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki